These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 32415710)

  • 61. Development of a new pharmacokinetic model for target-concentration controlled infusion of vancomycin in critically ill patients.
    Bang JY; Kang HI; Lee HJ; Chong YP; Hong SK; Lee EK; Choi BM; Noh GJ
    Clin Exp Pharmacol Physiol; 2022 Feb; 49(2):202-211. PubMed ID: 34596258
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Estimation of glomerular filtration rate to adjust vancomycin dosage in critically ill patients: superiority of the Chronic Kidney Disease Epidemiology Collaboration equation?
    Conil JM; Georges B; Breden A; Ruiz S; Cougot P; Fourcade O; Saivin S
    Anaesth Intensive Care; 2014 Mar; 42(2):178-84. PubMed ID: 24580382
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Model-Informed Precision Dosing of Vancomycin in Adult Patients Undergoing Hemodialysis.
    Oda K; Jono H; Saito H
    Antimicrob Agents Chemother; 2023 Jun; 67(6):e0008923. PubMed ID: 37195225
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Performance of a divided-load intravenous vancomycin dosing strategy for critically ill patients.
    Denetclaw TH; Dowling TC; Steinke D
    Ann Pharmacother; 2013 Dec; 47(12):1611-7. PubMed ID: 24259632
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Optimal dose of vancomycin for treating methicillin-resistant Staphylococcus aureus pneumonia in critically ill patients.
    Chung J; Oh JM; Cho EM; Jang HJ; Hong SB; Lim CM; Koh YS
    Anaesth Intensive Care; 2011 Nov; 39(6):1030-7. PubMed ID: 22165354
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Population pharmacokinetics and dosing simulations of cefuroxime in critically ill patients: non-standard dosing approaches are required to achieve therapeutic exposures.
    Carlier M; Noë M; Roberts JA; Stove V; Verstraete AG; Lipman J; De Waele JJ
    J Antimicrob Chemother; 2014 Oct; 69(10):2797-803. PubMed ID: 24917580
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Improving vancomycin prescription in critical illness through a drug use evaluation process: a weight-based dosing intervention study.
    Li J; Udy AA; Kirkpatrick CM; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2012 Jan; 39(1):69-72. PubMed ID: 22024354
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions.
    Roberts JA; Abdul-Aziz MH; Lipman J; Mouton JW; Vinks AA; Felton TW; Hope WW; Farkas A; Neely MN; Schentag JJ; Drusano G; Frey OR; Theuretzbacher U; Kuti JL;
    Lancet Infect Dis; 2014 Jun; 14(6):498-509. PubMed ID: 24768475
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Optimizing dosing of antibiotics in critically ill patients.
    Parker SL; Sime FB; Roberts JA
    Curr Opin Infect Dis; 2015 Dec; 28(6):497-504. PubMed ID: 26382000
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pharmacokinetic and Pharmacodynamic Characteristics of Vancomycin and Meropenem in Critically Ill Patients Receiving Sustained Low-efficiency Dialysis.
    Oliveira MS; Machado AS; Mendes ET; Chaves L; Perdigão Neto LV; Vieira da Silva C; Cavani Jorge Santos SR; Sanches C; Macedo E; Levin AS
    Clin Ther; 2020 Apr; 42(4):625-633. PubMed ID: 32199609
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pharmacokinetics and Target Attainment of Antibiotics in Critically Ill Children: A Systematic Review of Current Literature.
    Hartman SJF; Brüggemann RJ; Orriëns L; Dia N; Schreuder MF; de Wildt SN
    Clin Pharmacokinet; 2020 Feb; 59(2):173-205. PubMed ID: 31432468
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Switching From Intermittent to Continuous Infusion of Vancomycin in Critically Ill Patients: Toward a More Robust Exposure.
    van Maarseveen EM; Gipmans S; Vasbinder E; Petjak M; van Zanten AR
    Ther Drug Monit; 2016 Jun; 38(3):398-401. PubMed ID: 26926670
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evaluation of Continuous Infusion Vancomycin Administration in a Critically Ill Trauma Population.
    Bissell BD; Riggi G; Morrison C
    J Intensive Care Med; 2020 Jun; 35(6):570-575. PubMed ID: 29642744
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The relationship between trough concentration of vancomycin and effect on methicillin-resistant Staphylococcus aureus in critically ill patients.
    Cheong JY; Makmor-Bakry M; Lau CL; Abdul Rahman R
    S Afr Med J; 2012 May; 102(7):616-9. PubMed ID: 22748440
    [TBL] [Abstract][Full Text] [Related]  

  • 75. SaMpling Antibiotics in Renal Replacement Therapy (SMARRT): an observational pharmacokinetic study in critically ill patients.
    Roberts JA; Choi GY; Joynt GM; Paul SK; Deans R; Peake S; Cole L; Stephens D; Bellomo R; Turnidge J; Wallis SC; Roberts MS; Roberts DM; Lassig-Smith M; Starr T; Lipman J
    BMC Infect Dis; 2016 Mar; 16():103. PubMed ID: 26932762
    [TBL] [Abstract][Full Text] [Related]  

  • 76. New Regimen for Continuous Infusion of Vancomycin in Critically Ill Patients.
    Cristallini S; Hites M; Kabtouri H; Roberts JA; Beumier M; Cotton F; Lipman J; Jacobs F; Vincent JL; Creteur J; Taccone FS
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4750-6. PubMed ID: 27216073
    [TBL] [Abstract][Full Text] [Related]  

  • 77. CSF penetration of vancomycin in critical care patients with proven or suspected ventriculitis: a prospective observational study.
    Blassmann U; Hope W; Roehr AC; Frey OR; Vetter-Kerkhoff C; Thon N; Briegel J; Huge V
    J Antimicrob Chemother; 2019 Apr; 74(4):991-996. PubMed ID: 30689877
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Characterization of vancomycin pharmacokinetics in the adult acute myeloid leukemia population.
    Jarkowski A; Forrest A; Sweeney RP; Tan W; Segal BH; Almyroudis N; Wang ES; Wetzler M
    J Oncol Pharm Pract; 2012 Mar; 18(1):91-6. PubMed ID: 21521799
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Model-Informed Therapeutic Drug Monitoring of Meropenem in Critically Ill Patients: Improvement of the Predictive Ability of Literature Models with the PRIOR Approach.
    Chan Kwong A; O'Jeanson A; Khier S
    Eur J Drug Metab Pharmacokinet; 2021 May; 46(3):415-426. PubMed ID: 33830470
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Continuous intravenous vancomycin in children with normal renal function hospitalized in hematology-oncology: prospective validation of a dosing regimen optimizing steady-state concentration.
    Hoegy D; Goutelle S; Garnier N; Rénard C; Faure-Conter C; Bergeron C; Bertrand Y; Bleyzac N
    Fundam Clin Pharmacol; 2018 Jun; 32(3):323-329. PubMed ID: 29315849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.